Hyper IgE syndrome: review and future directions

References

• Davis SD, Schaller J, Wedgwood RJ. Job’s syndrome: recurrent, ‘cold’, staphylococcal abscesses. Lancet 1, 1013–1015 (1966).
   PubMed Web of Science ®Google Scholar
• Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 49, 59–70 (1972).
   PubMed Web of Science ®Google Scholar
• Grimbacher B, Holland SM, Gallin JI et al. Hyper-IgE syndrome with recurrent infections – an autosomal dominant multisystem disorder. N. Engl. J. Med. 340(9), 692–702 (1999).
   PubMed Web of Science ®Google Scholar
• Buckley RH. The hyper-IgE syndrome. Clin. Rev. Allergy Immunol. 20(1), 139–154 (2001).
   PubMed Web of Science ®Google Scholar
• Cohen-Solal M, Prieur AM, Prin L et al. Cytokine-mediated bone resorption in patients with the hyperimmunoglobulin E syndrome. Clin. Immunol. Immunopathol. 76(1 Pt 1), 75–81 (1995).
   PubMedGoogle Scholar
• Leung DY, Key L, Steinberg JJ et al. Creased in vitro bone resorption by monocytes in the hyper-immunoglobulin E syndrome. J. Immunol. 140(1), 84–88 (1988).
   PubMedGoogle Scholar
• Chamlin SL, McCalmont TH, Cunningham BB et al. Cutaneous manifestations of hyper-IgE syndrome in infants and children. J. Pediatr. 141(4), 572–575 (2002).
   PubMedGoogle Scholar
• Eberting CL, Davis J, Puck JM, Holland SM, Turner ML. Dermatitis and the newborn rash of hyper-IgE syndrome. Arch. Dermatol. 140(9), 1119–1125 (2004).
   PubMedGoogle Scholar
• Sheerin KA, Buckley RH. Antibody responses to protein, polysaccharide, and phi X174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. J. Allergy Clin. Immunol. 87(4), 803–811 (1991).
   PubMedGoogle Scholar
• Dreskin SC, Goldsmith PK, Gallin JI. Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job’s) syndrome. Deficiency of anti Staphylococcus aureus immunoglobulin. A.J. Clin. Invest. 75(1), 26–34 (1985).
   PubMedGoogle Scholar
• Geha RS, Reinherz E, Leung D, McKee KT Jr, Schlossman S, Rosen FS. Deficiency of suppressor T cells in the hyperimmunoglobulin E syndrome. J. Clin. Invest. 68(3), 783–791 (1981).
   PubMedGoogle Scholar
• Martinez AM, Montoya CJ, Rugeles MT, Franco JL, Patino PJ. Abnormal expression of CD54 in mixed reactions of mononuclear cells from hyper-IgE syndrome patients. Mem. Inst. Oswaldo Cruz. 99(2), 159–165 (2004).
   PubMedGoogle Scholar
• Erlewyn-Lajeunesse MD. Hyperimmunoglobulin-E syndrome with recurrent infection: a review of current opinion and treatment. Pediatr. Allergy Immunol. 11(3), 133–141 (2000).
   PubMedGoogle Scholar
• Ito R, Mori M, Katakura S et al. Selective insufficiency of IFN-γ secretion in patients with hyper-IgE syndrome. Allergy 58(4), 329–336 (2003).
   PubMedGoogle Scholar
• Chehimi J, Elder M, Greene J et al. Cytokine and chemokine dysregulation in hyper-IgE syndrome. Clin. Immunol. 100(1), 49–56 (2001).
   PubMedGoogle Scholar
• Rodriguez MF, Patino PJ, Montoya F, Montoya CJ, Sorensen RU, Garcia de Olarte D. Interleukin-4 and IFN-γ secretion by antigen and mitogen-stimulated mononuclear cells in the hyper-IgE syndrome: no Th-2 cytokine pattern. Ann. Allergy Asthma Immunol. 81(5), 443–447 (1998).
   PubMedGoogle Scholar
• Gudmundsson KO, Sigurjonsson OE, Gudmundsson S, Goldblatt D, Weemaes CM, Haraldsson A. Increased expression of interleukin-13 but not interleukin-4 in CD4+ cells from patients with the hyper-IgE syndrome. Clin. Exp. Immunol. 128(3), 532–537 (2002).
   PubMedGoogle Scholar
• Ohga S, Nomura A, Ihara K et al. Cytokine imbalance in hyper-IgE syndrome: reduced expression of transforming growth factor beta and IFN-γ genes in circulating activated T cells. Br. J. Haematol. 121(2), 324–331 (2003).
   PubMedGoogle Scholar
• Lewis DB, Liggitt HD, Effmann EL et al. Osteoporosis induced in mice by overproduction of interleukin-4. Proc. Natl Acad. Sci. USA 90(24), 11618–11622 (1993).
   PubMed Web of Science ®Google Scholar
• Tanaka T, Takada H, Nomura A, Ohga S, Shibata R, Hara T. Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome. Clin. Exp. Immunol. 140(3), 524–531 (2005).
   PubMedGoogle Scholar
• Hawn TR, Ozinsky A, Williams LM et al. Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes. Hum. Immunol. 66(7), 842–847 (2005).
   PubMedGoogle Scholar
• Renner ED, Pawlita I, Hoffmann F et al. No indication for a defect in toll-like receptor signaling in patients with hyper-IgE syndrome. J. Clin. Immunol. 25(4), 321–328 (2005).
   PubMedGoogle Scholar
• Leonard GD, Posadas E, Herrmann PC et al. Non-Hodgkin’s lymphoma in Job’s syndrome: a case report and literature review. Leuk. Lymphoma 45(12), 2521–2525 (2004).
   PubMed Web of Science ®Google Scholar
• Gorin LJ, Jeha SC, Sullivan MP, Rosenblatt HM, Shearer WT. Burkitt’s lymphoma developing in a 7-year-old boy with hyper-IgE syndrome. J. Allergy Clin. Immunol. 83(1), 5–10 (1989).
   PubMedGoogle Scholar
• Oztop I, Demirkan B, Tarhan O et al. The development of pulmonary adenocarcinoma in a patient with Job’s syndrome, a rare immunodeficiency condition. Tumori 90(1), 132–135 (2004).
   PubMedGoogle Scholar
• Grimbacher B, Dutra AS, Holland SM et al. Analphoid marker chromosome in a patient with hyper-IgE syndrome, autism, and mild mental retardation. Genet. Med. 1(5), 213–218 (1999).
   PubMedGoogle Scholar
• Grimbacher B, Schaffer AA, Holland SM et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am. J. Hum. Genet. 65(3), 735–744 (1999).
   PubMed Web of Science ®Google Scholar
• Grimbacher B, Holland SM, Puck JM. The interleukin-4 receptor variant Q576R in hyper-IgE syndrome. N. Engl. J. Med. 338(15), 1073–1074 (1998).
   PubMedGoogle Scholar
• Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor. N. Engl. J. Med. 337(24), 1720–1725 (1997).
   PubMed Web of Science ®Google Scholar
• Renner ED, Puck JM, Holland SM et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J. Pediatr. 144(1), 93–99 (2004).
   PubMed Web of Science ®Google Scholar
• Donabedian H, Alling DW, Gallin JI. Levamisole is inferior to placebo in the hyperimmunoglobulin E recurrent-infection (Job’s) syndrome. N. Engl. J. Med. 307(5), 290–292 (1982).
   PubMedGoogle Scholar
• Thompson RA, Kumararatne DS. Hyper-IgE syndrome and H2-receptor blockade. Lancet 2(8663), 630 (1989).
   Google Scholar
• Kimata H. High-dose intravenous γ-globulin treatment for hyperimmunoglobulinemia E syndrome. J. Allergy Clin. Immunol. 95(3), 771–774 (1995).
   PubMedGoogle Scholar
• King CL, Gallin JI, Malech HL, Abramson SL, Nutman TB. Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by IFN-γ. Proc. Natl Acad. Sci. USA 86(24), 10085–10089 (1989).
   PubMed Web of Science ®Google Scholar
• Dau PC. Remission of hyper-IgE syndrome treated with plasmapheresis and cytotoxic immunosuppression. J. Clin. Apher. 4(1), 8–12 (1988).
   PubMedGoogle Scholar
• Etzioni A, Shehadeh N, Brecher A, Yorman S, Pollack S. Cyclosporin A in hyperimmunoglobulin E syndrome. Ann. Allergy Asthma Immunol. 78(4), 413–414 (1997).
   PubMedGoogle Scholar
• Ishikawa I, Fukuda Y, Kitada H et al. Plasma exchange in a patient with hyper-IgE syndrome. Ann. Allergy 49(5), 295–297 (1982).
   PubMedGoogle Scholar
• Souillet G, Rousset F, de Vries JE. α-interferon treatment of patients with hyper IgE syndrome. Lancet 1(8651), 1384 (1989).
   PubMedGoogle Scholar
• Wolach B, Eliakim A, Pomeranz A, Cohen AH, Nusbacher J, Metzker A. Cyclosporin treatment of hyperimmunoglobulin E syndrome. Lancet 347(8993), 67 (1996).
   Google Scholar
• Gennery AR, Flood TJ, Abinun M, Cant AJ. Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant. 25(12), 1303–1305 (2000).
   PubMed Web of Science ®Google Scholar
• Nester TA, Wagnon AH, Reilly WF, Spitzer G, Kjeldsberg CR, Hill HR. Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections. Am. J. Med. 105(2), 162–164 (1998).
   PubMedGoogle Scholar